Results overview: Found 8 records in 0.02 seconds.
Articles, 7 records found
Research literature, 1 records found
Articles 7 records found  
1.
8 p, 1.6 MB DNA methylation of MMPs and TIMPs in atherothrombosis process in carotid plaques and blood tissues / Gallego-Fabrega, Cristina (Institut d'Investigació Biomèdica Sant Pau) ; Cullell, Natalia (Institut d'Investigació Biomèdica Sant Pau) ; Soriano-Tárraga, Carolina (Institut Hospital del Mar d'Investigacions Mèdiques) ; Carrera, Caty (Institut d'Investigació Biomèdica Sant Pau) ; Torres-Aguila, Nuria P. (Institut d'Investigació Biomèdica Sant Pau) ; Muiño, Elena (Institut d'Investigació Biomèdica Sant Pau) ; Cárcel-Márquez, Jara (Institut d'Investigació Biomèdica Sant Pau) ; de Moura, Manuel Castro (Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain) ; Fernández-Sanlés, Alba (Cardiovascular Epidemiology and Genetics Research Group, Hospital del Mar Medical Research Institute, Universitat Pompeu Fabra, Barcelona, Spain) ; Esteller, Manel (Institucio Catalana de Recerca i Estudis Avançats, Barcelona, Spain) ; Elosua, Roberto (Cardiovascular Epidemiology and Genetics Research Group, Hospital del Mar Medical Research Institute, Universitat Pompeu Fabra, Barcelona, Spain) ; Jiménez-Conde, Jordi (Institut Hospital del Mar d'Investigacions Mèdiques) ; Roquer, Jaume (Institut Hospital del Mar d'Investigacions Mèdiques) ; Montaner, Joan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Krupinski, Jerzy (* These authors contributed equally to this work) ; Fernandez-Cadenas, Israel (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Background and Purpose: Polymorphisms and serum levels of Matrix Metalloproteinases (MMP) and Tissue Inhibitor of Metalloproteinases (TIMP) have been studied with regard to atheromatous plaques and ischemic stroke, while no studies of DNA methylation (DNAm) patterns of MMP or TIMP have been performed to that end. [...]
2020 - 10.18632/oncotarget.27469
Oncotarget, Vol. 11 (march 2020) , p. 905-912  
2.
13 p, 2.8 MB Global proteomic and methylome analysis in human induced pluripotent stem cells reveals overexpression of a human TLR3 affecting proper innate immune response signaling / Requena, Jordi (Universitat de Barcelona. Departament de Biomedicina) ; Álvarez Palomo, Ana Belén (Universitat de Barcelona. Departament de Biomedicina) ; Codina Pascual, Montserrat (Universitat de Barcelona. Departament de Biomedicina) ; Delgado Morales, Raul (Institut d'Investigació Biomèdica de Bellvitge) ; Moran, Sebastian (Institut d'Investigació Biomèdica de Bellvitge) ; Esteller, Manel (Institut d'Investigació Biomèdica de Bellvitge) ; Sal, Martí (Universitat de Barcelona. Departament de Biomedicina) ; Juan, Manel (Universitat de Barcelona. Hospital Clínic. Servei d'Immunologia) ; Boronat Barado, Anna (Universitat de Barcelona. Hospital Clínic. Servei d'Immunologia) ; Consiglio, Antonella (Institut d'Investigació Biomèdica de Bellvitge) ; Bogle, Orleigh Addeleccia (Universitat de Barcelona. Departament de Biomedicina) ; Wolvetang, Ernst (University of Queensland. Australian Institute for Bioengineering and Nanotechnology) ; Ovchinnikov, Dmitry (University of Queensland. Australian Institute for Bioengineering and Nanotechnology) ; Álvarez Angulo, Iñaki (Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Jaraquemada, Dolores (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Mezquita Pla, Jovita (Universitat de Barcelona. Departament de Biomedicina) ; Oliva, R. (Universitat de Barcelona. Departament de Biomedicina) ; Edel, Michael J. (Universitat de Barcelona. Departament de Biomedicina)
When considering the clinical applications of autologous cell replacement therapy of human induced pluripotent stem cells (iPSC)-derived cells, there is a clear need to better understand what the immune response will be before we embark on extensive clinical trials to treat or model human disease. [...]
2019 - 10.1002/stem.2966
Stem Cells, Vol. 37, issue 4 (April 2019) , p. 476-488  
3.
28 p, 1.0 MB Label-free DNA-methylation detection by direct ds-DNA fragment screening using poly-purine hairpins / Sánchez Huertas, César (Institut Català de Nanociència i Nanotecnologia) ; Aviñó, Anna (Institut de Química Avançada de Catalunya) ; Kurachi, Cristina (Institut Català de Nanociència i Nanotecnologia) ; Piqué, Albert (Institut Català de Nanociència i Nanotecnologia) ; Sandoval, Juan (Institut de Recerca Biomèdia Bellvitge) ; Eritja, Ramon (Institut de Química Avançada de Catalunya) ; Esteller, Manel (Institucio Catalana de Recerca i Estudis Avançats (ICREA)) ; Lechuga, Laura M. (Institut Català de Nanociència i Nanotecnologia)
Cancer diagnosis continuously evolves due to the better understanding of tumorigenic processes. DNA-methylation is consolidated as an effective biomarker for cancer prognosis and diagnostic even in tumors of unknown origin. [...]
2018 - 10.1016/j.bios.2018.08.027
Biosensors and bioelectronics, Vol. 120 (November 2018) , p. 47-54  
4.
12 p, 2.5 MB Cancer network activity associated with therapeutic response and synergism / Serra-Musach, Jordi (Institut Català d'Oncologia (ICO)) ; Mateo, Francesca (Institut Català d'Oncologia (ICO)) ; Capdevila-Busquets, Eva (Institut de Recerca Biomèdica (IRB Barcelona)) ; de Garibay, Gorka Ruiz (Institut Català d'Oncologia (ICO)) ; Zhang, Xiaohu (National Institutes of Health. Medical Center Dr. Rockville. National Center for Advancing Translational Sciences (NCATS)) ; Guha, Raj (National Institutes of Health. Medical Center Dr. Rockville. National Center for Advancing Translational Sciences (NCATS)) ; Thomas, Craig J. (National Institutes of Health. Medical Center Dr. Rockville. National Center for Advancing Translational Sciences (NCATS)) ; Grueso, Judit (Institut d'Oncologia de la Vall Hebron (VHIO)) ; Villanueva, Alberto (Institut Català d'Oncologia (ICO).) ; Jaeger, Samira (Institut de Recerca Biomèdica (IRB Barcelona)) ; Heyn, Holger (Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)) ; Vizoso, Miguel (Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)) ; Pérez, Hector (Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)) ; Cordero, Alex (Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)) ; Gonzalez-Suarez, Eva (Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)) ; Esteller, Manel (Institució Catalana de Recerca i Estudis Avançats (ICREA)) ; Moreno-Bueno, Gema (Universidad Autónoma de Madrid. Departamento de Bioquímica) ; Tjärnberg, Andreas (Linköping University. Departament of Clinical and Experimental Medicine) ; Lázaro, Conxi (Institut Català d'Oncologia (ICO)) ; Serra, Violeta (Institut d'Oncologia de la Vall Hebron (VHIO)) ; Arribas, Joaquín V. (Vicente) (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Benson, Mikael (Linköping University. Department of Clinical and Experimental Medicine) ; Gustafsson, Mika (Linköping University. Department of Clinical and Experimental Medicine) ; Ferrer, Marc (National Institutes of Health. Medical Center Dr. Rockville. National Center for Advancing Translational Sciences (NCATS)) ; Aloy, Patrick (Institució Catalana de Recerca i Estudis Avançats (ICREA)) ; Pujana, Miquel Àngel (Institut Català d'Oncologia (ICO))
Cancer patients often show no or only modest benefit from a given therapy. This major problem in oncology is generally attributed to the lack of specific predictive biomarkers, yet a global measure of cancer cell activity may support a comprehensive mechanistic understanding of therapy efficacy. [...]
2016 - 10.1186/s13073-016-0340-x
Genome Medicine, Vol. 8 (August 2016) , ART. 88  
5.
7 p, 15.8 MB Study of breast cancer incidence in patients of lymphangioleiomyomatosis / Nuñez, Olivier (Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, and Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP)) ; Román, Antonio (Hospital Universitari Vall d'Hebron) ; Johnson, Simon R. (National Centre for Lymphangioleiomyomatosis, Nottingham University Hospitals NHS Trust, Nottingham, Nottinghamshire, UK Division of Respiratory Medicine and Respiratory Research Unit, University of Nottingham) ; Inoue, Yoshikazu (National Hospital Organization Kinki-Chuo Chest Medical Center) ; Hirose, Masaki (National Hospital Organization Kinki-Chuo Chest Medical Center) ; Casanova, Álvaro (Department of Pneumology, Henares Hospital) ; de Garibay, Gorka Ruiz (ProCURE, Breast Cancer and Systems Biology, Catalan Institute of Oncology (ICO) Institute for Biomedical Research (IDIBELL),) ; Herranz-Ors, C. (ProCURE, Breast Cancer and Systems Biology, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL)) ; Bueno-Moreno, Gema (MD Anderson International Foundation) ; Boni, Jacopo (ProCURE, Breast Cancer and Systems Biology, Catalan Institute of Oncology (ICO) for Biomedical Research (IDIBELL), Gran via 199, L'Hospitalet del Llobregat) ; Mateo, Francesca (ProCURE, Breast Cancer and Systems Biology, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL)) ; Petit Montserrat, Anna (Department of Pathology, University Hospital of Bellvitge, IDIBELL) ; Climent, Fina (Department of Pathology, University Hospital of Bellvitge, IDIBELL) ; Soler, Teresa (Department of Pathology, University Hospital of Bellvitge, IDIBELL) ; Vidal, August (Department of Pathology, University Hospital of Bellvitge, IDIBELL) ; Sánchez-Mut, José Vicente (Cancer Epigenetics and Biology Program, IDIBELL) ; Esteller, Manel (Catalan Institution for Research and Advanced Studies (ICREA)) ; López, José Ignacio (Cruces University Hospital, BioCruces Research Institute, University of the Basque Country) ; García, Nadia (ProCURE, Breast Cancer and Systems Biology, Catalan Institute of Oncology (ICO)Institute for Biomedical Research (IDIBELL), Gran via 199) ; Gumà, Anna (Department of Radiology, University Hospital of Bellvitge, IDIBELLBarcelona, Catalonia Spain) ; Ortega, Raúl (Department of Radiology, University Hospital of Bellvitge, IDIBELL) ; Plà, María Jesús (Breast Cancer Functional Unit, Department of Gynecology, University Hospital of Bellvitge, ICO, IDIBELL) ; Campos, Miriam (Breast Cancer Functional Unit, Department of Medical Oncology, ICO, IDIBELL) ; Ansótegui, Emilio (Lung Transplant and Cystic Fibrosis Unit, Hospital Universitario y Politecnico La Fe) ; Molina-Molina, María (Consortium for Biomedical Research in Respiratory Diseases (CIBERES), 28029 Madrid, Spain) ; Valenzuela, Claudia (Department of Pneumology, Instituto de Investigación Sanitaria La Princesa) ; Ussetti, Piedad (Department of Pneumology, University Hospital Clínica Puerta del Hierro) ; Laporta, Rosalía (Department of Pneumology, University Hospital Clínica Puerta del Hierro) ; Ancochea, Julio (Department of Pneumology, Instituto de Investigación Sanitaria La Princesa, Hospital La Princesa,) ; Xaubet, Antoni (Department of Pneumology, Hospital Clinic of Barcelona, August Pi Suñer Biomedical Research Institute (IDIBAPS)) ; Pollán, Marina (Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, and Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP)) ; Pujana, Miguel Angel (ProCURE, Breast Cancer and Systems Biology, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL)) ; Universitat Autònoma de Barcelona. Departament de Medicina
The online version of this article (doi:10. 1007/s10549-016-3737-8) contains supplementary material, which is available to authorized users.
2016 - 10.1007/s10549-016-3737-8
Breast Cancer Research and Treatment, Vol. 156 (march 2016) , p. 195-201  
6.
14 p, 4.9 MB Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs / Nogales, Vanesa (Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain) ; Reinhold, William C. (Genomics and Bioinformatics Group, Developmental Therapeutics Branch, National Cancer Institute, Bethesda, MD, USA) ; Varma, Sudhir (Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA) ; Martinez-Cardus, Anna (Institut de Recerca Biomèdica Bellvitge (IDIBELL)) ; Moutinho, Catia (Institut de Recerca Biomèdica Bellvitge (IDIBELL)) ; Moran, Sebastian (Institut de Recerca Biomèdica Bellvitge (IDIBELL)) ; Heyn, Holger (Institut de Recerca Biomèdica Bellvitge (IDIBELL)) ; Sebio, Ana (Institut d'Investigació Biomèdica Sant Pau) ; Barnadas i Molins, Agustí (Institut d'Investigació Biomèdica Sant Pau) ; Pommier, Yves (Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA) ; Esteller, Manel (Institucio Catalana de Recerca i Estudis Avançats (ICREA)) ; Universitat Autònoma de Barcelona
Platinum-derived drugs such as cisplatin and carboplatin are among the most commonly used cancer chemotherapy drugs, but very few specific molecular and cellular markers predicting differential sensitivity to these agents in a given tumor type have been clearly identified. [...]
2015 - 10.18632/oncotarget.6413
Oncotarget, Vol. 7 (november 2015) , p. 3084-3097  
7.
2 p, 90.5 KB Manel Esteller / Esteller, Manel (Centro Nacional de Investigaciones Oncológicas (Madrid, Espanya)) ; Gallegos Riera, Pablo ; Santos, Lucas
Manel Esteller estudia les alteracions genètiques de les malalties. Ha participat en el desenvolupament de fàrmacs per tractar el càncer i de noves tecnologies per a la investigació en aquest àmbit.
2006
UAB divulga, maig 2006, p. 1-1 (Entrevistes)  

Research literature 1 records found  
1.
167 p, 3.7 MB Alteraciones epigenéticas en modelos murinos y humanos de enfermedad de Alzheimer / Sánchez Mut, Jose Vicente ; Esteller Badosa, Manel, dir. ; Navarro, Xavier (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia
La enfermedad de Alzheimer (EA) es una patología neurodegenerativa devastadora. Es la principal causa de demencia en las sociedades occidentales y actualmente no tiene cura. Sus síntomas no son evidentes hasta estados muy avanzados y su origen sigue siendo desconocido. [...]
Alzheimer's disease (AD) is a devastating neurodegenerative disorder. It is the main cause of dementia in Western societies and currently has no cure. Symptoms only appear in late stages and it origin remains unknown. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2014  

See also: similar author names
3 Esteller, M
1 Esteller, M.
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.